DiscoverThe Mind-Full Method22 | Microdosing & Mental Health
22 | Microdosing & Mental Health

22 | Microdosing & Mental Health

Update: 2022-05-03
Share

Description

Welcome to the Head to Heal Podcast


Heads up! I am not a medical doctor and you should always seek help from a physician before beginning any new health regime.


On this weeks Episode Jiordana talks all about Microdosing and and how to use it with various mental health disorders and to make positive changes in your brain.


We cover:



  • What Microdosing is

  • How it works

  • Why mental health disorders are resistant to change

  • When to use microdosing (and when to not)

  • Info on Microdosing course




Hit the LIKE & SUBSCRIBE button! This keeps the information free and available to everyone.


Don't forget to share this episode with someone who you feel can value from it!




Links:


Website: www.themindfullclinic.com


Instagram: @themindfullclinic


Email: jiordana@themindfullclinic.com




References:


Argento, E., Capler, R., Thomas, G., Lucas, P., & Tupper, K. W. (2019b). Exploring ayahuasca‐assisted therapy for addiction: A qualitative analysis of preliminary findings among an indigenous community in Canada. Drug and Alcohol Review, 38(7), 781–789. https://doi.org/10.1111/dar.12985


Carhart-Harris, R. L., Kaelen, M., Bolstridge, M., Williams, T. M., Williams, L. T., Underwood, R., ... Nutt, D. J. (2016). The paradoxical psychological effects of lysergic acid diethylamide (LSD). Psychological Medicine, 46(7), 1379–1390. https://doi.org/10.1017/s0033291715002901


Dos Santos, R. G., Osório, F. L., Crippa, J. A., Riba, J., Zuardi, A. W., & Hallak, J. E. (2016). Antidepressive, anxiolytic, and antiaddictive effects of ayahuasca, psilocybin and lysergic acid diethylamide (LSD): a systematic review of clinical trials published in the last 25 years. Therapeutic Advances in Psychopharmacology, 6(3), 193–213. https://doi.org/10.1177/204512531663800


Ezquerra-Romano, I., Lawn, W., Krupitsky, E., & Morgan, C. J. A. (2018). Ketamine for the treatment of addiction: Evidence and potential mechanisms. Neuropharmacology, 142, 72–82. https://doi.org/10.1016/j.neuropharm.2018.01.017

Comments 
00:00
00:00
x

0.5x

0.8x

1.0x

1.25x

1.5x

2.0x

3.0x

Sleep Timer

Off

End of Episode

5 Minutes

10 Minutes

15 Minutes

30 Minutes

45 Minutes

60 Minutes

120 Minutes

22 | Microdosing & Mental Health

22 | Microdosing & Mental Health

Jiordana Saade